YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
AI data centers are drawing political fire for their heavy energy use, yet demand for computing power keeps building. That same tension is playing out in healthcare, where Canadian companies using artificial intelligence to read scans, sup…
Global debt costs are climbing, with interest bills now larger than many governments spend on AI itself. That squeeze on public budgets is pushing attention toward private companies building real AI tools that healthcare providers can pay…
Price targets for Healwell AI have been adjusted within a CA$1.50 to CA$2.00 range, with some analysts moving up to CA$2.00 and others trimming down to CA$1.50. This split reflects different views on how recent quarterly execution lines up…
Pentavere advances from winning the 2024 Prix Galien USA Award to competing internationally among Prix Galien winners from around the world, further validating DARWEN™ AI as a globally recognized healthcare AI platform The broader 2026 Int…
* 20/20 Biolabs, Inc. press release [https://seekingalpha.com/pr/20620918-20-20-biolabs-reports-second-quarter-2026-financial-results-and-recent-operational-progress] (AIDX [https://seekingalpha.com/symbol/AIDX]): Q2 GAAP EPS of -$0.26. *…
Chief Executive Officer Jonathan Cohen to Discuss BIO Asia-Taiwan Participation and Strategic Meetings in Taipei, Tokyo, and Seoul Webinar to Be Held Wednesday, August 5, 2026 at 12:00 p.m. Eastern Time; Registration Is Now Open GAITHERSBU…
Management Met with Potential Acquisition, Licensing, Joint Venture, and Commercial Partners Across the Region Initiative Aims to Expand Mission of Saving Lives Through Early Detection and Prevention of Cancers and Chronic Diseases GAITHER…
Agreement Temporarily Restricts Preferred-to-Common Stock Conversions Below a Defined Price Threshold, Mitigating Potential Near-Term Dilution GAITHERSBURG, Md., July 23, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: AIDX) (the “Co…
Company Outlines Strategy to Position OneTest™ as the First Affordable, Multi-Cancer Early Detection Blood Test for Earlier Stage Detection GAITHERSBURG, Md., July 09, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: AIDX) (the “Compa…
Inaugural Session to be Held Wednesday, July 1, 2026, at 12:00 p.m. ET Recurring Forum Intended to Increase Transparency, Strengthen Shareholder Communication, and Provide Investors with Direct Access to Management GAITHERSBURG, Md., June…
(RTTNews) - Biotech companies are seeing significant pre-market activity this Monday. Price swings ahead of the opening bell are being driven by clinical trial and regulatory updates, as well as trial endpoint misses. In the Green - Premar…
(RTTNews) - Biotech stocks are showing strong pre-market moves this Tuesday, hinting at possible breakout setups. Assessing sentiment and momentum in the premarket sets the tone for a trader's day. In the Green - Premarket Gainers On Tuesd…
(RTTNews) - 20/20 Biolabs, Inc. (AIDX), a diagnostic firm focused on laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, announced that it is developing contingency plans to potentially supp…
(RTTNews) - 20/20 BioLabs, Inc. (AIDX) reported its financial results for the first quarter, reflecting a revenue slip for the period ending March 31, 2026. Meanwhile, looking ahead to the second quarter of 2026, the firm said that, based…
HEALWELL appoints Brad Porter, Chief Commercial Officer of HEALWELL and CEO of Orion Health, to its Board of Directors to strengthen the Company's commercial and strategic expertise. Ian McCrae is stepping down from the Board of Directors…
State-Funded Screening Initiative Highlights Growing Public Sector Support for Innovative Cancer Detection Tools GAITHERSBURG, Md., March 27, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (Nasdaq: AIDX), an early market entrant in AI powere…
(RTTNews) - 20/20 BioLabs, Inc., (AIDX) is strengthening its position in the fast-growing longevity analytics space after securing an exclusive U.S. license to integrate ROKIT Healthcare's chronic kidney disease (CKD) prediction algorithm…
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Healwell AI is back in focus after analysts trimmed fair value from CA$3.45 to CA$2.85, roughly a 17% reset to their modeled price…
20/20 Biolabs Inc. Recently Nasdaq-Listed Company Introduces Longevity Blood Test Integrating Inflammatory Biomarkers, Dietary Habits, and Curated Scientific Research to Deliver Personalized Health Insights GAITHERSBURG, Md., Feb. 25, 2026…
HEALWELL, in collaboration with Takeda Pharmaceutical, presented new AI generated and regulatory-grade real-world data (RWD) on vedolizumab dose escalation in ulcerative colitis and Crohn's disease at the prestigious United European Gastro…
Healwell AI (AIDX) reported a significant increase in revenue and profitability for the second quarter of fiscal year 2025, driven by strong performance in its healthcare software segment. The company’s stock surged 13.57% following the ea…
* Healwell AI (OTCQX:HWAIF [https://seekingalpha.com/symbol/HWAIF]) on Tuesday said [https://seekingalpha.com/pr/20167309-healwell-provides-corporate-update-including-improved-performance-in-ai-business-acquisition]preliminary H1 2025 reve…